Daniel O'Connor Net Worth

Daniel O'Connor biography

Daniel J. O'Connor J.D. serves as President, Chief Executive Officer, Director of the Company. Mr. O'Connor brings more than 20 years of successful financing and licensing experience to OncoSec's Board of Directors, most recently serving as President and Chief Executive Officer of Advaxis Immunotherapies. His appointment to the Company's Board is effective immediately. Most recently, as President and Chief Executive Officer of Advaxis Immunotherapies, Mr. O'Connor successfully turned around the company, raising more than $250 million in funding and transforming it into a patient-focused, leading cancer immunotherapy company. He was also instrumental in establishing major partnerships with companies that include Amgen Inc., Merck & Co. and Bristol Myers Squibb. In addition, under his leadership, the company advanced four new cancer immunotherapy drug candidates into clinical trials, as well as several PD-1 combination clinical studies with Keytruda® and Opdivo®. Previously, Mr. O'Connor was Senior Vice President for ImClone Systems where he supported the clinical development, launch, and commercialization of ERBITUX®, and the sale of the company to Eli Lilly in 2008. Mr. O'Connor served as General Counsel at PharmaNet (inventive Health) and was part of the senior leadership team that grew the company from a start-up contract research organization into a leader in clinical research. Mr. O'Connor is a 1995 graduate of the Penn State University's Dickinson School of Law in Carlisle, Pennsylvania and currently serves as an Entrepreneur Trusted Advisor to its Dean. He graduated from the United States Marines Corps Officer Candidate School in 1988 and was commissioned as an officer in the U.S. Marines, attaining the rank of Captain while serving in Saudi Arabia during Operation Desert Shield. Mr. O'Connor is currently the Vice Chairman of BioNJ and was a former New Jersey criminal prosecutor.

What is the salary of Daniel Connor?

As the President, Chief Executive Officer, and Director of OncoSec Medical Inc, the total compensation of Daniel Connor at OncoSec Medical Inc is $1,176,720. There are no executives at OncoSec Medical Inc getting paid more.